semaglutide and mental health Depression: What the Science Shows Semaglutide Shows Surprising Mental Health

Emerging therapies, such as Tirzepatide, a dual GLP-1/GIP agonist, and Orforglipron, a nonpeptide oral GLP-1 RA, continue to expand the potential of this medication class in treating metabolic diseases (23)(24)

Fibroblasts are like construction workers: They move into damage sites, building new tissue scaffolding

AOD-9604 liberates fat from adipocytes, but liberated fat sitting in plasma does nothing except potentially raise LDL-C if it's not oxidised

They also note that milder side effects, such as gastrointestinal complaints and other potential reasons for discontinuation, cannot be captured fully in registries and were likely underestimated